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Abstract
Centronuclear myopathies (CNM) describe a group of rare muscle diseases typically presenting an abnormal posi-
tioning of nuclei in muscle fibers. To date, three genes are known to be associated to a classical CNM phenotype.
The X-linked neonatal form (XLCNM) is due to mutations in MTM1 and involves a severe and generalized muscle
weakness at birth. The autosomal dominant form results from DNM2 mutations and has been described with early
childhood and adult onset (ADCNM). Autosomal recessive centronuclear myopathy (ARCNM) is less characterized
and has recently been associated to mutations in BIN1, encoding amphiphysin 2. Here we present the first clinical
description of intrafamilal variability in two first-degree cousins with a novel BIN1 stop mutation. In addition to ske-
letal muscle defects, both patients have mild mental retardation and the more severely affected male also displays
abnormal ventilation and cardiac arrhythmia, thus expanding the phenotypic spectrum of BIN1-related CNM to non
skeletal muscle defects. We provide an up-to-date review of all previous cases with ARCNM and BIN1 mutations.
Background
Centronuclear myopathies (CNM) are a group of conge-
nital disorders characterized by hypotonia and skeletal
muscle biopsies typically showing small rounded fibers
with central nuclei [1-4]. Abnormal nuclear positioning
is seen in several myopathies, but clinical, genetic and
pathological factors clearly distinguish these myopathies
from CNM. Three CNM classes have been described:
the severe neonatal X-linked form, also called myotubu-
lar myopathy (XLCNM, OMIM 310400), the autosomal
recessive form with childhood onset (ARCNM, OMIM
255200), and the autosomal dominant form with adult
onset (ADCNM, OMIM 160150). Myotubularin
(MTM1) is mutated in XLCNM [5] and belongs to a
l a r g ef a m i l yo fu b i q u i t o u s l ye x p r e s s e dp h o s p h o i n o s i t i d e
phosphatases implicated in intracellular vesicle traffick-
ing [6-8]. The large GTPase dynamin 2 (DNM2),
mutated in ADCNM, is a mechanochemical enzyme and
a key factor in membrane trafficking and endocytosis
[9-11]. Amphiphysin 2 (BIN1)i sm u t a t e di nA R C N M
and possesses an N-terminal BAR domain able to sense
and bend membranes and a SH3 domain mediating pro-
tein-protein interactions [12,13]. A muscle-specific iso-
form is implicated in T-tubule biogenesis and contains a
polybasic residue sequence binding to phosphoinositides
[14]. Only 4 unrelated individuals with BIN1 mutations
have been molecularly and clinically characterized to
date [12,15] and this report is the first description of
intrafamilal variability in two patients from a consangui-
neous family. Clinical analysis of respiratory and cardiac
involvement diagnosed for the more severely affected
male patient expand the phenotypic spectrum in autoso-
mal recessive centronuclear myopathy. It is furthermore
the first time that patients with a BIN1 mutation are
analyzed by whole-body MRI and the results contrast
previous findings on DNM2-related CNM.
Clinical report and results
Patient 1 is a 13 year old girl belonging to a consangui-
neous family from Turkey without ancestral history of
neuromuscular disorders (Figure 1A-B). There were no
complications during pregnancy, antenatal signs for
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any medium, provided the original work is properly cited.Figure 1 Clinical, histological and MRI features in the patients. (A) Pedigree of the consanguineous family of both ARCNM patients.
Segregation of the mutation (c.1717C > T in NM_139343) in the tested individuals is depicted as black dots; both patients are homozygous for
the mutation while all four parents are heterozygous. Other individuals were not tested. The related parents have 3 brothers and 2 sisters, and
the male patient has 1 sister and 2 brothers. (B) Photos of both patient 1 (on the left) and patient 2 (right). (C) T1 weighted coronal whole body
MRI images of patients 1 (left) and 2 (right) and axial displays of the femoral and the lower leg regions (below, middle panel) demonstrate
prominent fatty involvement of soleus [2], tibialis anterior, peroneal and extensor muscles [1], but sparing of the gastrocnemius [3]. All thigh
muscle groups were affected without selective pattern. Imaging of upper limb demonstrated relative sparing of triceps [1] and arrows, left
picture, lower panel], subscapularis [2] and flexor [3] and arrows, right picture, lower panel] muscle groups. (D) Muscle biopsy from patient 2
showing small rounded fibers with a high percentage of central nuclei, variable fiber size, extensive fibrosis, and (F) electron microscopy image
showing myofibrillar disorganization. (E) Muscle biopsy of patient 2 with normal Dystrophin labeling.
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Page 2 of 6muscle disorders as polyhydramnios and reduced fetal
movements were not noted. Hypotonia was diagnosed at
birth and motor development was delayed: head control
was achieved at 6 months, walking at 18 months and
running at 36 months. Muscle weakness was predomi-
nantly proximal, accompanied by mild facial weakness,
ptosis and ophtalmoplegia/paresis. Tendinous reflexes
were absent and she has no contractures. Although she
has mild mental retardation (IQ 60), speech develop-
ment was normal and she integrated the regular educa-
tional system. Echocardiography, electrocardiography
and electroneuromyography were normal, and there
were no indications of myotonia or neuromuscular junc-
tion abnormalities. Serum creatine kinase was mildly ele-
vated [380 IU/L (70-150); normal range 60 - 320 IU/L].
She is currently walking independently but she has diffi-
culty climbing stairs and running. Pulmonary function
tests are normal. Patient 1 has one non-affected sister
and none of the parents displays clinical features of a
muscle disorder.
Patient 2, a 14 year old boy, is the first-degree cousin
of patient 1 and belongs to a second consanguineous
family loop (Figure 1A-B). The course of the disease
was rather similar to patient 1 with normal pregnancy,
hypotonia at birth, delayed motor milestones and nor-
mal speech development despite a mild mental retarda-
tion (IQ 60). Head control was achieved at 6 months,
walking at 18 months and running at 36 months. Like-
wise, patient 2 presents a predominantly proximal
muscle weakness, absent tendinous reflexes, facial weak-
ness, ptosis and opthalmoplegia/paresis. However, his phe-
notype is more severe as he is not able to walk
independently since the age of 10 years and is wheelchair-
bound. Furthermore, the degree of ophtalmoplegia/paresis
and ptosis is more prominent than in patient 1. In addi-
tion, electrocardiography and HOLTER examination
revealed premature ventricular complexes while echocar-
diography was normal. Serum creatine kinase was 450 IU/
L (70-150) and electromyography revealed myopathic
changes in all muscle groups. He needs non-invasive
respiratory support for four hours per day. Patient 2 has
healthy parents and 3 non-affected siblings.
Whole body MRI of both patients revealed similar
results with increased signals on T2 and T1 weighted
images in thigh muscles, upper and lower extremities
which are consistent with fatty infiltrations. Detailed
axial imaging of the femoral and crural regions of patient
1 revealed prominent fatty involvement of soleus, tibialis
anterior, peroneal and extensor muscles, but sparing of
the gastrocnemius (Figure 1C). All thigh muscle groups
were affected without selective pattern. Imaging of upper
limb demonstrated relative sparing of triceps, subscapu-
laris and flexor muscle groups (Figure 1C). No abnormal-
ities of brain, heart or other organs were noted.
Diagnosis of CNM for both patients was suggested on
muscle biopsies showing numerous centrally located and
partially clustered nuclei, variable fiber size, type 1 fiber
predominance, extensive myofibrillar disorganization
(Figure 1F) and fibrosis (Figure 1D). Dystrophin expres-
sion was normal (Figure 1E). BIN1 sequencing revealed
ah o m o z y g o u sn o n s e n s em u t a t i o ni ne x o n2 0i nb o t h
patients (c.1717C > T; p.Gln573stop). Both patients have
healthy parents heterozygous for this mutation.
Discussion
By direct sequencing of the 20 BIN1 exons and the adja-
cent splice-relevant regions we identified the novel
homozygous nonsense BIN1 mutation p.Gln573stop in
two first-degree cousins from a consanguineous family.
Both patients present predominantly proximal muscle
weakness and classical features of CNM with a general
progressive hypotonia involving facial weakness and pto-
sis. Ophtalmoplegia/paresis, as seen in both patients, is
not a common sign of ARCNM (Table 1), while it is
consistently reported for the X-linked form. However,
Ophtalmoplegia/paresis often evolves over time and
might not have been diagnosed in all BIN1 patients due
to their young age. Whole body MRI showed fatty infil-
trations of different muscle groups with selective muscle
involvement in the lower leg, and a general muscle
involvement in the thigh. This contrasts MRI findings in
DNM2-related centronuclear myopathies where promi-
nent fatty atrophy was predominantly documented in
the lower leg muscles, but only in specific thigh muscles:
increased signals were reported for adductor longus,
semimembranosus, rectus femoris, biceps femoris, and
vastus intermedius muscles, while the adductor magnus,
gracilis, sartorius, semitendinosus, vastus lateralis, and
vastus medialis muscles were only minimally affected
[16].
This is consistent with the observation that ARCNM
patients with BIN1 mutations predominantly display a
proximal muscle weakness (Table 1), whereas ADCNM
patients with DNM2 mutations rather present involve-
ment of the distal muscles [17]. Characterization of
additional ARCNM and ADCNM patients is required to
confirm that MRI could be used as a differential marker
to direct genetic diagnosis.
To our knowledge, this is the second documented
ARCNM family with more than one molecularly charac-
terized member. Nicot et al. reported a family with
three affected members, two of which died within the
first year of life, precluding a long term comparison of
clinical signs [[12], Table 1]. In the present study we
observed a clear intra-familiar variability, which might
be linked to gender or modifier genes differing between
individuals. Patient 2 does not walk independently, has a
more pronounced ophtalmoplegia/paresis and ptosis,
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Page 3 of 6Table 1 Clinical comparison of all patients with known BIN1 mutations
Patient Sex Mutation
1 AA
change
Origin Age
of
onset
Age
2 Central
nuclei
Pregnancy Ventilation Muscle
weakness
Facial
weakness
Ptosis Ophtalmoplegia/
paresis
Other
phenotypes
Cognitive
development
Cardiac
function
Reference
Family
1
AAT68 male c.105G >
T
p.
LysK35Asn
India birth 12 ++ reduced fetal
movements,
oligohydramnios,
IUGR
3
normal proximal,
slowly
progressive
no yes yes contractures
at birth
normal normal [12]
ACC82 female c.105G >
T
p.
LysK35Asn
India birth died
at
1year
+ reduced fetal
movements,
oligohydramnios,
IUGR
normal proximal no no no contractures
at birth
hypodevelopment
of frontal lobes
died from
myocarditis
[12]
ADS5 female no DNA
available
n.d. India birth died
at 18
hrs
n.d. reduced fetal
movements,
oligohydramnios,
IUGR, premature
birth
lung
hypoplasia,
ventilated
from birth,
died from
respiratory
failure
no
spontaneous
movements
n.d. n.d. n.d. severe joint
contractures
at birth
n.d. prenatal
heart
enlarged,
postnatal
ECG
normal
[12]
Family
2
ADR71 male c.451G >
A
p.
Asp151Asn
Iraq 8 35 ++ normal n.d. proximal n.d no no no normal normal [12]
Single
case
AEY47 male c.461G >
A
pArg154Gln Morocco 11 21 ++ normal respiratory
insufficiency
diffuse
atrophy,
slowly
progressive
yes yes yes Scapular
winging,
hyperlordosis,
left-sided
kyphoscoliosis
IQ 70 normal [15]
This
family
AFG89
(patient
1)
female c.1717C >
T
p.
Gln573stop
Turkey birth 13 ++ normal normal proximal yes yes yes no IQ 60 normal this study
AFG92
(patient
2)
male c.1717C >
T
p.
Gln573stop
Turkey birth 14 ++ normal respiratory
insufficiency
proximal yes yes yes no IQ 60 cardiac
arrhythmia
this study
Family
3
LF41 male c.1723A >
T
p.
Lys575stop
Iraq birth 14 ++ normal respiratory
insufficiency
proximal,
slowly
progressive
yes yes yes scoliosis normal normal [12,18]
1Nucleotide numbering from the A of the ATG start codon in BIN1-iso1 reference sequence (NM_139343).
2At time of publication (yrs)
3Intrauterine growth restriction
4Mejaddam et al., 2009 reported the detailed histopathological characterization of patient LF41 described in Nicot et al., 2007.
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6and electroneuromyography revealed myopathic changes
not detected in patient 1. Patient 2 has also been diag-
nosed for additional respiratory system and cardiac
involvements. Abnormal ventilation has been documen-
ted for two other autosomal recessive cases [[15,18],
Table 1] and a further patient died at birth due to
respiratory failure [[12], Table 1]. Cardiac arrhythmia
was stated for patient 2, while ECG examinations did
not reveal abnormalities for patient 1. As cardiac
abnormalities have been reported for another ARCNM
patient who died from myocarditis shortly after birth
[[12], Table 1], we suggest careful cardiac function
examinations and long term follow-up of patients with
BIN1 mutations.
A mild mental retardation, as seen in both patients,
has recently been described in another ARCNM patient
[[15], Table 1]. Mental impairment was not noticed in
the other BIN1-patients and is rarely present in other
CNM forms. However, decreased synaptic vesicle recy-
cling in the murine brain was described in amphiphysin
1 knockout mice, suggesting a possible pathological
mechanism affecting cognitive abilities [19]. We though
cannot exclude that the mental retardation might not be
correlated to the BIN1 mutation, especially in a consan-
guineous family.
BIN1 was initially identified as a c-Myc interacting
pro-apoptotic tumor suppressor [20]; BIN1 expression is
reduced in several cancers and mice deficient for BIN1
develop more aggressive tumors [21,22]. However, no
tumors were reported in the small set of ARCNM
patients with BIN1 mutations.
The novel p.Gln573stop mutation described in this
study is in direct spatial proximity to the previously
identified p.Lys575stop mutation, which results in the
expression of a truncated protein with decreased dyna-
min 2 binding [12]. At the time of publication, the
p.Lys575stop patient was 17 years old, able to walk
short distances, had normal cognitive development and
no cardiac involvement [[12,18], Table 1], contrasting
the present study. Table 1 gives an overview of the clini-
cal manifestations of all currently published BIN1
patients. Disease onset at birth was stated for all patients
except for ADR71 and AEY47 (p.Asp151Asn and
pArg154Gln, respectively), harboring adjacent missense
mutations in the BAR-domain and presenting a gener-
ally milder etiopathology. The identification of more
BIN1 mutations and respective detailed clinical descrip-
tions might help to establish an unambiguous genotype/
phenotype correlation and to clarify if the most 3’ BIN1
exon represents a hot spot prone to mutations.
In conclusion, this study expands the phenotypic spec-
trum of BIN1-related centronuclear myopathy and is the
first clinical description of intrafamilial variability in a
consanguineous CNM family.
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